China Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027
Summary
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Chinese pharmaceuticals market had total revenues of $213.2 billion in 2022, representing a compound annual growth rate (CAGR) of 12% between 2017 and 2022.
0
The Chinese market acquired a 50.2% share of the Asia-Pacific pharmaceuticals market in 2022. China has implemented policies to address unmet clinical needs in the pharmaceutical market, including new approval and regulatory processes for drug development and therapeutic applications. Acceleration programs allow for rapid access to product application reviews for products with significant clinical value.
Scope
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in China
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in China
Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts
Reasons to Buy
What was the size of the China pharmaceuticals market by value in 2022?
What will be the size of the China pharmaceuticals market in 2027?
What factors are affecting the strength of competition in the China pharmaceuticals market?
How has the market performed over the last five years?
What are the main segments that make up China's pharmaceuticals market?
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What strategies do leading players follow?
7.3. What are the most recent market developments?
8 Company Profiles
8.1. Yangtze River Pharmaceutical Group
8.2. Shanghai Pharmaceuticals Holding Co Ltd
8.3. Yunnan Baiyao Group Co Ltd
8.4. Guangzhou Pharmaceutical Holdings Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: China pharmaceuticals market value: $ billion, 2017-22
Table 2: China pharmaceuticals market geography segmentation: $ billion, 2022
Table 3: China pharmaceuticals market value forecast: $ billion, 2022-27
Table 4: Yangtze River Pharmaceutical Group: key facts
Table 5: Yangtze River Pharmaceutical Group: Key Employees
Table 6: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 7: Shanghai Pharmaceuticals Holding Co Ltd: Annual Financial Ratios
Table 8: Shanghai Pharmaceuticals Holding Co Ltd: Key Employees
Table 9: Yunnan Baiyao Group Co Ltd: key facts
Table 10: Yunnan Baiyao Group Co Ltd: Annual Financial Ratios